Shagun Singh
Stock Analyst at RBC Capital
(3.44)
# 945
Out of 5,150 analysts
251
Total ratings
51.67%
Success rate
2.88%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Sector Perform | $115 → $125 | $119.18 | +4.88% | 24 | Feb 27, 2026 | |
| INSP Inspire Medical Systems | Maintains: Sector Perform | $90 → $68 | $64.32 | +5.72% | 10 | Feb 12, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $210 → $172 | $171.49 | +0.30% | 5 | Feb 10, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $130 → $115 | $72.21 | +59.26% | 19 | Feb 5, 2026 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $240 → $255 | $245.30 | +3.95% | 24 | Feb 3, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $147 → $135 | $113.10 | +19.36% | 18 | Jan 23, 2026 | |
| PEN Penumbra | Downgrades: Sector Perform | $355 → $374 | $339.61 | +10.13% | 16 | Jan 20, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $625 → $650 | $501.18 | +29.69% | 18 | Dec 17, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $92 → $100 | $90.46 | +10.55% | 9 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $100 | $85.22 | +17.34% | 24 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $370 → $380 | $242.89 | +56.45% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $118 | $95.60 | +23.43% | 22 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $22 → $17 | $3.53 | +381.59% | 14 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $101 | $95.75 | +5.48% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $85 | $72.90 | +16.60% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $23.41 | +6.79% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $381.89 | +13.91% | 19 | Jan 29, 2025 |
Teleflex
Feb 27, 2026
Maintains: Sector Perform
Price Target: $115 → $125
Current: $119.18
Upside: +4.88%
Inspire Medical Systems
Feb 12, 2026
Maintains: Sector Perform
Price Target: $90 → $68
Current: $64.32
Upside: +5.72%
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Sector Perform
Price Target: $210 → $172
Current: $171.49
Upside: +0.30%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $130 → $115
Current: $72.21
Upside: +59.26%
Johnson & Johnson
Feb 3, 2026
Maintains: Outperform
Price Target: $240 → $255
Current: $245.30
Upside: +3.95%
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $147 → $135
Current: $113.10
Upside: +19.36%
Penumbra
Jan 20, 2026
Downgrades: Sector Perform
Price Target: $355 → $374
Current: $339.61
Upside: +10.13%
Intuitive Surgical
Dec 17, 2025
Maintains: Outperform
Price Target: $625 → $650
Current: $501.18
Upside: +29.69%
Globus Medical
Dec 17, 2025
Maintains: Outperform
Price Target: $92 → $100
Current: $90.46
Upside: +10.55%
Edwards Lifesciences
Dec 5, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $85.22
Upside: +17.34%
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $242.89
Upside: +56.45%
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $95.60
Upside: +23.43%
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $3.53
Upside: +381.59%
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $95.75
Upside: +5.48%
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $72.90
Upside: +16.60%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $23.41
Upside: +6.79%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $381.89
Upside: +13.91%